Oculomotor changes as differential diagnosis in Parkinsonian syndromes;Untersuchung der okulomotorik als differenzialdiagnostisches instrument bei Parkinson-syndromen

Nervenheilkunde

Volumn 30, Issue 4, 2011, Pages 259-262

  Pinkhardt, E H ^a   Kassubek, J ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Differential diagnosis; Eye movement disorders; Idiopathic Parkinson's disease; Multiple system atrophy; Progressive supranuclear palsy

Indexed keywords

DIFFERENTIAL DIAGNOSIS; EYE MOVEMENT DISORDER; NEUROPATHOLOGY; PARKINSONISM; REVIEW; VIDEOOCULOGRAPHY;

EID: 79953722257     PISSN: 07221541     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1627799     Document Type: Review

References (40)

1. Williams DR, Lees AJ. How do patients with parkinsonism present? A clinicopathological study. Intern Med J 2009; 39(1): 7-12.
2. Williams DR, Lees AJ. What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsy-parkinsonism (PSP-P)? Mov Disord 2010; 25(3): 357-62.
3. Poewe W. Treatments for Parkinson disease - past achievements and current clinical needs. Neurology 2009; 72(7 Suppl): S65-73.
4. Dickson DW et al. Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria. Lancet Neurol 2009; 8(12): 1150-7.
5. Dickson DW, Rademakers R, Hutton ML. Progressive supranuclear palsy: pathology and genetics. Brain Pathol 2007; 17(1): 74-82.
6. Foulds P et al. Parkinson disease: Progress towards a molecular biomarker for Parkinson disease. Nat Rev Neurol 2010; 6(7): 359-61.
7. Anderson T et al. Oculomotor function in multiple system atrophy: clinical and laboratory features in 30 patients. Mov Disord 2008; 23(7): 977-84.
8. Leigh RJ, Zee DS. The neurology of eye movements. 4th ed. Oxford: Oxford University Press 2006.
9. Eggert T. Eye movement recordings: methods. Dev Ophthalmol 2007; 40: 15-34.
10. van der Geest JN, Frens MA. Recording eye movements with video-oculography and scleral search coils: a direct comparison of two methods. J Neurosci Methods 2002; 114(2): 185-95. (Pubitemid 34150122)
11. Amador SC et al. Dissociating cognitive deficits involved in voluntary eye movement dysfunctions in Parkinson's disease patients. Neuropsychologia 2006; 44(8): 1475-82.
12. Armstrong IT et al. Control of saccades in Parkinson's disease. Brain Cogn 2002; 49(2): 198-201.
13. Briand KA et al. Control of voluntary and reflexive saccades in Parkinson's disease. Exp Brain Res 1999; 129(1): 38-48. (Pubitemid 29494838)
14. Chan F et al. Deficits in saccadic eye-movement control in Parkinson's disease. Neuropsychologia 2005; 43(5): 784-96. (Pubitemid 40254347)
15. Vidailhet M et al. Eye movements in parkinsonian syndromes. Ann Neurol 1994; 35(4): 420-6.
16. Kimmig H et al. What is pathological with gaze shift fragmentation in Parkinson's disease? J Neurol 2002; 249(6): 683-92.
17. MacAskill MR, Anderson TJ, Jones RD. Adaptive modification of saccade amplitude in Parkinson's disease. Brain 2002; 125(Pt 7): 1570-82. (Pubitemid 34755171)
18. Blekher T et al. Multiple step pattern as a biomarker in Parkinson disease. Parkinsonism Relat Disord 2009; 15(7): 506-10.
19. Blekher T et al. Test-retest reliability of saccadic measures in subjects at risk for Huntington disease. Invest Ophthalmol Vis Sci 2009; 50(12): 5707-11.
20. Tusa RJ, Ungerleider LG. Fiber pathways of cortical areas mediating smooth pursuit eye movements in monkeys. Ann Neurol 1988; 23(2): 174-83. (Pubitemid 18081456)
21. Pinkhardt EH et al. Comparison of smooth pursuit eye movement deficits in multiple system atrophy and Parkinson's disease. J Neurol 2009; 256(9): 1438-46.
22. Pierrot-Deseilligny C et al. Decisional role of the dorsolateral prefrontal cortex in ocular motor behaviour. Brain 2003; 126(Pt 6): 1460-73. (Pubitemid 36644389)
23. Mosimann UP et al. Saccadic eye movement changes in Parkinson's disease dementia and dementia with Lewy bodies. Brain 2005; 128(6): 1267-76. (Pubitemid 40826181)
24. van Stockum S et al. Don't look now or look away: two sources of saccadic disinhibition in Parkinson's disease? Neuropsychologia 2008; 46(13): 3108-15.
25. Salman MS, Sharpe JA, Lillakas L, Steinbach MJ. Square wave jerks in children and adolescents. Pediatr Neurol 2008; 38(1): 16-9. (Pubitemid 350181287)
26. Crevits L et al. Antisaccadic effects of a dopamine agonist as add-on therapy in advanced Parkinson's patients. Neuropsychobiology 2000; 42(4): 202-6.
27. Gibson JM, Kennard C. Quantitative study of "onoff" fluctuations in the ocular motor system in Parkinson's disease. Adv Neurol 1987; 45: 329-33.
28. Vermersch AI et al. Sequences of memory-guided saccades in Parkinson's disease. Ann Neurol 1994; 35(4): 487-90.
29. Rivaud-Pechoux S et al. Improvement of memory guided saccades in parkinsonian patients by high frequency subthalamic nucleus stimulation. J Neurol Neurosurg Psychiatry 2000; 68(3): 381-4. (Pubitemid 30248719)
30. Sauleau P et al. Subthalamic stimulation improves orienting gaze movements in Parkinson's disease. Clin Neurophysiol 2008; 119(8): 1857-63.
31. Temel Y, Visser-Vandewalle V, Carpenter RH. Saccadic latency during electrical stimulation of the human subthalamic nucleus. Curr Biol 2008; 18(10): R412-4.
32. Yugeta A et al. Effects of STN stimulation on the initiation and inhibition of saccade in Parkinson disease. Neurology 2010; 74(9): 743-8.
33. Harrison J, Henderson L, Kennard C. Abnormal refractoriness in patients with Parkinson's disease after brief withdrawal of levodopa treatment. J Neurol Neurosurg Psychiatry 1995; 59(5): 499-506.
34. Ozawa T et al. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain 2004; 127(Pt 12): 2657-71. (Pubitemid 39627375)
35. Bhidayasiri R, Riley DE, Somers JT, Lerner AJ, Buttner-Ennever JA, Leigh RJ. Pathophysiology of slow vertical saccades in progressive supranuclear palsy. Neurology 2001; 57(11): 2070-7.
36. Pinkhardt EH et al. Differential diagnostic value of eye movement recording in PSP-parkinsonism, Richardson's syndrome, and idiopathic Parkinson's disease. J Neurol 2008; 255(12): 1916-25.
37. Revesz T, Sangha H, Daniel SE. The nucleus raphe interpositus in the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Brain 1996; 119( Pt 4): 1137-43. (Pubitemid 26300716)
38. Ludolph AC et al. Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. Eur J Neurol 2009; 16(3); 297-309.
39. Williams DR et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain 2005; 128(Pt 6): 1247-58. (Pubitemid 40826179)
40. Rivaud-Pechoux S et al. Longitudinal ocular motor study in corticobasal degeneration and progressive supranuclear palsy. Neurology 2000; 54(5): 1029-32. (Pubitemid 30151841)